Top compounds associated with response to GYPC


Feature Type Standardized
Nominal ANOVA
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.13 0.003
mRNA BHG712 GDSC1000 pan-cancer AAC 0.13 0.004
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.12 0.004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.004
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.004
mRNA SU11274 CTRPv2 pan-cancer AAC -0.12 0.004
mRNA TAE684 CTRPv2 pan-cancer AAC -0.12 0.005
mRNA CD-437 CTRPv2 pan-cancer AAC -0.11 0.005
mRNA AT13387 CTRPv2 pan-cancer AAC -0.16 0.005
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.1 0.005
Download CSV